We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » The FDA Seeks $22 Million in User Fees for Reinspections
The FDA Seeks $22 Million in User Fees for Reinspections
February 24, 2006
Device and drug manufacturers may find themselves coughing up more money to pay proposed FDA user fees that would fund the agency’s reinspections of manufacturing plants that fail initial review.